Kane

Biography

He joined Amarin  has more than 20 years of senior financial and operational management experience including over 15 years supporting the growth of life science companies. Mr. Thero became president and CEO of Amarin in 2014 after previously being the company's president and initially the company's chief financial officer. Prior to Amarin, Mr. Thero was at ViaCell, Inc., where as chief financial officer he helped guide the company to its successful sale, and Abiomed, Inc., where he held multiple positions, including senior vice president business operations and chief financial officer, and helped manage the company's transition from a development-stage company into a commercial entity. Mr. Thero began his professional career at Arthur Andersen LLP.  He joined Amarin  has more than 20 years of senior financial and operational management experience including over 15 years supporting the growth of life science companies. Mr. Thero became president and CEO of Amarin in 2014 after previously being the company's president and initially the company's chief financial officer. Prior to Amarin, Mr. Thero was at ViaCell, Inc., where as chief financial officer he helped guide the company to its successful sale, and Abiomed, Inc., where he held multiple positions, including senior vice president business operations and chief financial officer, and helped manage the company's transition from a development-stage company into a commercial entity. Mr. Thero began his professional career at Arthur Andersen LLP. 

Research Interest

commercialization and development of therapeutics to improve cardiovascular health. Amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids